YOLT-204

N/A

Report date: 2024/12/09 20:01:07

Base Information

Drug NameYOLT-204
Drug Alias NameYOLT-204
ClassificationCell and gene therapy > Gene therapy > LNP
Mechanisms of ActionGene expression modulators
TargetsUpdating
Therapy Area/IndicationsGenetic Diseases, Inbornbeta-ThalassemiaAnemia, Sickle Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Yaotang Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFirst Affiliated Hospital Of Guangxi Medical UniversityGuangzhou Women And Children'S Medical CenterShanghai Yaotang Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsGenetic Diseases, Inbornbeta-ThalassemiaAnemia, Sickle Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A